Organogenesis Holdings Inc. (ORGO) financial statements (2020 and earlier)

Company profile

Business Address 85 DAN ROAD
CANTON, MA 02021
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments602101
Cash and cash equivalents602101
Restricted cash and investments00  
Receivables3934  
Inventory, net of allowances, customer advances and progress billings2313  
Inventory2313  
Prepaid expense3200
Total current assets:1267101
Noncurrent Assets
Property, plant and equipment4740  
Long-term investments and receivables10  
Due from related parties10  
Intangible assets, net (including goodwill)4652  
Goodwill2626  
Intangible assets, net (excluding goodwill)2126  
Restricted cash and investments  312310
Other noncurrent assets11  
Other undisclosed noncurrent assets00  
Total noncurrent assets:9593312310
TOTAL ASSETS:221164313311
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities524540
Accounts payable2819  
Accrued liabilities232540
Debt 10  
Due to related parties  0 
Business combination, contingent consideration, liability55  
Other undisclosed current liabilities37 0
Total current liabilities:606640
Noncurrent Liabilities
Long-term debt and lease obligation5049  
Long-term debt, excluding current maturities5039  
Capital lease obligations10  
Liabilities, other than long-term debt81  
Deferred rent credit10
Other liabilities71  
Other undisclosed noncurrent liabilities48 1111
Total noncurrent liabilities:105501111
Total liabilities:1651171511
Temporary equity, carrying amount  293295
Stockholders' equity
Stockholders' equity attributable to parent, including:564755
Common stock00  
Additional paid in capital22717775
Accumulated deficit(171)(130)(2)(0)
Other undisclosed stockholders' equity attributable to parent  00
Total stockholders' equity:564755
TOTAL LIABILITIES AND EQUITY:221164313311

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues261193  
Cost of revenue(76)(69)  
Gross profit:185125  
Operating expenses(214)(176)(5)(0)
Operating loss:(29)(52)(5)(0)
Nonoperating income (expense)(11)(13)2 
Investment income, nonoperating 02 
Interest and debt expense(2)(2)  
Loss from continuing operations before equity method investments, income taxes:(42)(67)(2)(0)
Other undisclosed income from continuing operations before income taxes22  
Loss from continuing operations before income taxes:(40)(65)(2)(0)
Income tax expense(0)(0)  
Net loss attributable to parent:(40)(65)(2)(0)
Other undisclosed net loss available to common stockholders, basic(1) (2) 
Net loss available to common stockholders, diluted:(41)(65)(4)(0)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(40)(65)(2)(0)
Comprehensive loss, net of tax, attributable to parent:(40)(65)(2)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: